Latest filing published 28 Feb 2025 for Skye Bioscience, Inc., €1,001.
Filing timeline
BuySaleInsider track record
Kaitlyn Arsenault: trading record in brief
Kaitlyn Arsenault discloses dealings in Skye Bioscience, Inc. to SEC (Form 4). In total, 8 filings cover trades dated from 25 August 2023 to 18 November 2024.
Sales make up the whole of the open-market record (4 sales, €410k). Other entries cover 4 share grants. In 2025 alone, the filings show no purchases and 2 sales.
Most recently, on 28 February 2025, the filings show an open-market sale worth €204k in Skye Bioscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kaitlyn Arsenault
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 190 shares@ US$5.550.5% of flowCommon StockSEC:0001516551-25-000022:0
- 190 shares@ US$5.550.5% of flowCommon StockSEC:0001516551-24-000117:0
- 43,206 shares@ US$4.9999.5% of flowCommon StockSEC:0001516551-24-000117:1
- 25,000 shares0Common StockSEC:0001516551-24-000016:0
- 25,000 shares0Common StockSEC:0001516551-24-000012:0
- 128,209 shares0Common StockSEC:0001516551-23-000096:0
- 13,382,118 shares0Common StockSEC:0001516551-23-000064:0
7 of 7 declarations